Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO

Ralf Dieter Hofheinz; Georg Martin Haag; Thomas Jens Ettrich; Kersten Borchert; Albrecht Kretzschmar; Christian Teschendorf; Gabriele Margareta Siegler; Matthias Philip Ebert; Eray Goekkurt; Manfred Welslau; Rolf Mahlberg; Nils Homann; Daniel Pink; Wolf Otto Bechstein; Peter Reichardt; Timo Gaiser; Disorn Sookthai; Claudia Pauligk; Thorsten Oliver Goetze; Salah-Eddin Al-Batran

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO

Ralf Dieter Hofheinz, Georg Martin Haag, Thomas Jens Ettrich, Kersten Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Margareta Siegler, Matthias Philip Ebert, Eray Goekkurt, Manfred Welslau, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf Otto Bechstein, Peter Reichardt, Timo Gaiser, Disorn Sookthai, Claudia Pauligk, Thorsten Oliver Goetze, Salah-Eddin Al-Batran

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

60 Citations (Web of Science)

Original language	Undefined/Unknown
Journal	Journal of Clinical Oncology
Publication status	Published - 2020

Cite this

Hofheinz, R. D., Haag, G. M., Ettrich, T. J., Borchert, K., Kretzschmar, A., Teschendorf, C., Siegler, G. M., Ebert, M. P., Goekkurt, E., Welslau, M., Mahlberg, R., Homann, N., Pink, D., Bechstein, W. O., Reichardt, P., Gaiser, T., Sookthai, D., Pauligk, C., Goetze, T. O., & Al-Batran, S.-E. (2020). Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO. Journal of Clinical Oncology.

@article{ef5f5fe8ae034749a38b52835c9112f2,

title = "Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO",

author = "Hofheinz, {Ralf Dieter} and Haag, {Georg Martin} and Ettrich, {Thomas Jens} and Kersten Borchert and Albrecht Kretzschmar and Christian Teschendorf and Siegler, {Gabriele Margareta} and Ebert, {Matthias Philip} and Eray Goekkurt and Manfred Welslau and Rolf Mahlberg and Nils Homann and Daniel Pink and Bechstein, {Wolf Otto} and Peter Reichardt and Timo Gaiser and Disorn Sookthai and Claudia Pauligk and Goetze, {Thorsten Oliver} and Salah-Eddin Al-Batran",

year = "2020",

language = "Undefined/Unknown",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

}

Hofheinz, RD, Haag, GM, Ettrich, TJ, Borchert, K, Kretzschmar, A, Teschendorf, C, Siegler, GM, Ebert, MP, Goekkurt, E, Welslau, M, Mahlberg, R, Homann, N, Pink, D, Bechstein, WO, Reichardt, P, Gaiser, T, Sookthai, D, Pauligk, C, Goetze, TO & Al-Batran, S-E 2020, 'Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO', Journal of Clinical Oncology.

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO. / Hofheinz, Ralf Dieter; Haag, Georg Martin; Ettrich, Thomas Jens et al.
In: Journal of Clinical Oncology, 2020.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO

AU - Hofheinz, Ralf Dieter

AU - Haag, Georg Martin

AU - Ettrich, Thomas Jens

AU - Borchert, Kersten

AU - Kretzschmar, Albrecht

AU - Teschendorf, Christian

AU - Siegler, Gabriele Margareta

AU - Ebert, Matthias Philip

AU - Goekkurt, Eray

AU - Welslau, Manfred

AU - Mahlberg, Rolf

AU - Homann, Nils

AU - Pink, Daniel

AU - Bechstein, Wolf Otto

AU - Reichardt, Peter

AU - Gaiser, Timo

AU - Sookthai, Disorn

AU - Pauligk, Claudia

AU - Goetze, Thorsten Oliver

AU - Al-Batran, Salah-Eddin

PY - 2020

Y1 - 2020

UR - https://publons.com/wos-op/publon/35235612/

M3 - Originalarbeit

SN - 0732-183X

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO

Other files and links

Cite this